Background illustration for clinical trials search

Paid Clinical Trials Lincoln

Discover 604 paid clinical trials in Lincoln, Nebraska. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2
Active & Responsive

A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events

for
Diabetes Mellitus, Type 2, PreDiabetes, Metabolic Syndrome
Location: Lincoln NE, West Des Moines IA, Tulsa OK,
Sponsor: Cleerly, Inc.

Sex: All

Age: 55+

Code: NCT06112418

Recruiting
Active & Responsive

Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention

for
Percutaneous Coronary Intervention,
Location: Lincoln NE, Omaha NE, Grand Island NE,
Sponsor: Duke University

Sex: All

Age: 18+

Code: NCT06909565

Recruiting
Active & Responsive

OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events

for
Cardiovascular Disease
Location: Lincoln NE, West Des Moines IA, Kansas City KS,
Sponsor: Amgen

Sex: All

Age: 50 - 70+

Code: NCT07136012

Phase3, Recruiting
Active & Responsive

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

for
Atherosclerotic Cardiovascular Disease, Overweight, Obesity
Location: Lincoln NE, Papillion NE, Omaha NE, Topeka KS,
Sponsor: Amgen

Sex: All

Age: 45 - 70+

Code: NCT07037433

Phase3, Recruiting
Active & Responsive

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

for
Heart Failure With Preserved Ejection Fraction,
Location: Lincoln NE, Kansas City KS, Kansas City MO, Lenexa KS,
Sponsor: Amgen

Sex: All

Age: 18 - 70+

Code: NCT07037459

Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

Assessment of CCM in HF With Higher Ejection Fraction

for
Heart Failure, Heart Failure With Preserved Ejection Fraction,
Location: Lincoln NE, West Des Moines IA, Kansas City KS,
Sponsor: Impulse Dynamics

Sex: All

Age: 18+

Code: NCT05064709

Recruiting
Active & Responsive

Anastomotic Safety and Surveillance Using Real-time Enhanced Sensing Using xBar

for
Colorectal Cancer
Location: Lincoln NE, Louisville KY, Pittsburgh PA, Baltimore MD,
Sponsor: Exero Medical Ltd.

Sex: All

Age: 21+

Code: NCT07337590

Recruiting
Active & Responsive

Prevalence of Antibodies and Cytokines in Participants With Chronic Granulomatous Disease

for
Chronic Granulomatous Disease (CGD)
Location: Lincoln NE, Topeka KS, Des Moines IA, Jefferson City MO,
Sponsor: Ensoma

Sex: All

Age: 0+

Code: NCT06605378

Recruiting
Active & Responsive

Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS

for
Amyotrophic Lateral Sclerosis
Location: Lincoln NE, Fairway KS, St Louis MO, Aurora CO,
Sponsor: Prilenia

Sex: All

Age: 18 - 70+

Code: NCT07322003

Phase3, Recruiting
Active & Responsive

A Clinical Trial of Calderasib (MK-1084) and Durvalumab in People With Non-Small Cell Lung Cancer (MK-1084-015/KANDLELIT-015)

for
Non-small Cell Lung Cancer
Location: Lincoln NE, Fairfax VA, Raleigh NC, Albany NY
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT07554339

Phase3, Recruiting
Active & Responsive

A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)

for
Non-small Cell Lung Cancer
Location: Lincoln NE, Sioux Falls SD, Peoria IL, Fargo ND,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT07513376

Phase3, Recruiting
Active & Responsive

A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression

for
Treatment Resistant Depression
Location: Lincoln NE, Kansas City KS, Columbia MO, Tulsa OK,
Sponsor: LivaNova

Sex: All

Age: 18+

Code: NCT03887715

Recruiting
Active & Responsive

ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant Response

for
Major Depressive Disorder (MDD),
Location: Lincoln NE, Saint Charles MO, Denver CO, Flowood MS,
Sponsor: ACADIA Pharmaceuticals Inc.

Sex: All

Age: 18 - 65

Code: NCT07284667

Phase2, Recruiting
Active & Responsive

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

for
Intestinal Neoplasms, Gastrointestinal Neoplasms,
Location: Lincoln NE, Yankton SD, Sioux Falls SD, Mitchell SD,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT07222800

Phase3, Recruiting
Active & Responsive

Study of Oral MRT-2359 With Apalutamide in Prostate Cancer

for
Castration-Resistant Prostate Cancer (CRPC),
Location: Omaha NE, West Valley City UT, East Brunswick NJ,
Sponsor: Monte Rosa Therapeutics, Inc

Sex: Male

Age: 18+

Code: NCT07745361

Phase2, Recruiting
Active & Responsive

A Study of [225Ac]Ac-AKY-2519 in Patients With Metastatic Castration-Resistant Prostate Cancer

for
Castration Resistant Metastatic Prostate Cancer,
Location: Omaha NE, Kansas City KS, Grand Rapids MI, Irvine CA,
Sponsor: Aktis Oncology, Inc.

Sex: Male

Age: 18+

Code: NCT07581184

Phase1, Recruiting
Active & Responsive

177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors

for
Castration-Resistant Prostate Cancer (CRPC), Colorectal Cancer,
Location: Omaha NE, Grand Rapids MI, Dothan AL
Sponsor: Radiopharm Theranostics, Ltd

Sex: All

Age: 18+

Code: NCT07189871

Phase1, Phase2, Recruiting
Active & Responsive

A Study To Assess the Safety, Tolerability, and Efficacy of Imzokitug in Combination With Pumitamig and Platinum-Doublet Chemotherapy (PDCT) Versus Pumitamig and PDCT as First-line Treatment for Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

for
Locally Advanced Non-Small Cell Lung Cancer (NSCLC),
Location: Omaha NE, Grand Island NE
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT07680764

Phase2, Recruiting
Active & ResponsiveNew

Zanzalintinib Alone or in Combination With Pembrolizumab and Berahyaluronidase Alfa in Participants With Colorectal Cancer With Molecular Residual Disease

for
Colorectal Cancer
Location: Omaha NE, Papillion NE, Council Bluffs IA,
Sponsor: Exelixis

Sex: All

Age: 18+

Code: NCT07750158

Phase3, Recruiting
Active & Responsive

A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

for
NSCLC Adenocarcinoma, Gastroesophageal Cancer (GC),
Location: Omaha NE, Rochester MN, Zion IL, Irving TX,
Sponsor: IDEAYA Biosciences

Sex: All

Age: 18+

Code: NCT07277413

Phase1, Recruiting